ne response to the shortage of cadaver organs 0 has been to evaluate donors previously not considered suitable. One group consists of donors who are hepatitis B surface antigen-negative (HBsAg[ -1) and hepatitis B core antibody-positive (HBcAb[+]). We present a case report of an individual receiving
Risk for de novo hepatitis B from antibody to hepatitis B core antigen—Positive donors in liver transplantation in Singapore
✍ Scribed by Kang H. Lee; Chun T. Wai; Seng G. Lim; Kaur Manjit; Hwee L. Lee; Maureen Da Costa; Seng H. Quak; Kai-Chah Tan
- Publisher
- John Wiley and Sons
- Year
- 2003
- Tongue
- English
- Weight
- 35 KB
- Volume
- 7
- Category
- Article
- ISSN
- 1527-6465
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
A variety of prophylactic strategies are used to prevent the risk of hepatitis B virus (HBV) transmission from antibody to hepatitis B core antigen (anti-HBc)-positive donors. The mechanisms underlying the failure of HBV immunoglobulin monoprophylaxis have been poorly evaluated. Seventy-seven anti-H
Liver transplantation using grafts from donors with antibody against hepatitis B core antigen (anti-HBc) increases the recipients' risk of developing hepatitis B virus (HBV) infection post-transplantation. Our aim was to assess whether using such grafts was associated with reduced posttransplantatio
## Abstract The prevalence of serum HBV DNA in individuals positive for anti‐HBc alone was determined by the polymerase chain reaction in two groups with endemic HBV infection from Canton (group A) and Hainan (group B), provinces of China. Twenty‐one out of 294 individuals in group A (7.2%) and 193
Prophylactic therapy is generally used to prevent reactivated hepatitis B after transplantation of an antibody to hepatitis B core antigen (anti-HBc)-positive liver. To gain insight into current practice, a questionnaire was e-mailed to 89 liver transplant physicians in the United States, Europe, an